Arifine 5 Tablet is a prescription drug, available for use as Tablet. It is typically used for the treatment of Schizophrenia, Mania. Secondary and off-label uses of Arifine 5 Tablet have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Arifine 5 Tablet. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
Common side effects of Arifine 5 Tablet include Back Pain, Dizziness, Drowsiness. While these are the most often observed Arifine 5 Tablet side effects, there are can be others also. These have been listed below. Usually, these side effects of Arifine 5 Tablet go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Arifine 5 Tablet is Moderate for pregnant women and Severe for women who are breastfeeding. Warnings related to Arifine 5 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Arifine 5 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Arifine 5 Tablet in conditions like Bradycardia (Slow Heart Rate), Tardive Dyskinesia, Dementia. The section on Arifine 5 Tablet contraindications lists all such conditions.
Additionally, Arifine 5 Tablet may also adversely react with other medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Arifine 5 Tablet is considered not safe while driving, and is not addictive.
Arifine 5 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Is the use of Arifine 5 Tablet safe for pregnant women?
Arifine can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Arifine right away. Take your doctor's advice before taking it again.
Is the use of Arifine 5 Tablet safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Arifine. It should only be taken after medical advice.
What is the effect of Arifine 5 Tablet on the Kidneys?
There are no side effects of Arifine on the kidneys.
What is the effect of Arifine 5 Tablet on the Liver?
Arifine is completely safe for the liver.
What is the effect of Arifine 5 Tablet on the Heart?
Arifine may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Arifine 5 Tablet unless your doctor advises you to do so -
Is this Arifine 5 Tablet habit forming or addictive?
No, there is no any evidence that Arifine 5 Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
After taking Arifine 5 Tablet, you should not drive or work on any heavy machine, as Arifine 5 Tablet can make you drowsy.
Is it safe?
Yes, Arifine 5 Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Yes, Arifine 5 Tablet is useful in treating mental disorders.
Interaction between Food and Arifine 5 Tablet
Taking Arifine 5 Tablet with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Arifine 5 Tablet
Taking Arifine 5 Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Abilify® (aripiprazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 440,442
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 184-188
